Stein, Switzerland

Hannes Nussbaumer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Syngenta Participations Ag. Active years: 2017.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hannes Nussbaumer: Innovator in Stereoselective Chemistry

Introduction

Hannes Nussbaumer is a notable inventor based in Stein, Switzerland. He has made significant contributions to the field of chemistry, particularly in the area of stereoselective synthesis. His innovative work has led to the development of a unique process that enhances the preparation of specific chemical compounds.

Latest Patents

Hannes Nussbaumer holds 1 patent for his invention titled "Process for the stereoselective preparation of a pyrazole-carboxamide." This patent describes a method for the enantioselective preparation of a compound through a series of steps involving reduction, acylation, and coupling, ultimately leading to the desired compound.

Career Highlights

Nussbaumer is currently associated with Syngenta Participations AG, a leading company in agricultural science. His work at Syngenta focuses on advancing chemical processes that can have significant applications in various fields, including pharmaceuticals and agrochemicals.

Collaborations

Throughout his career, Hannes has collaborated with talented professionals such as Raphael Dumeunier and Sebastian Volker Wendeborn. These collaborations have fostered an environment of innovation and creativity, contributing to the success of their projects.

Conclusion

Hannes Nussbaumer's contributions to stereoselective chemistry exemplify the impact of innovative thinking in scientific research. His patent and work at Syngenta highlight the importance of advancements in chemical processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…